Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
about
Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and ToxicityA panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.Plasma anti-BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer.
P2860
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
@ast
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
@en
type
label
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
@ast
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
@en
prefLabel
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
@ast
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
@en
P2093
P2860
P1433
P1476
Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer
@en
P2093
Cairen Chen
Leiguang Ye
Qingyong Meng
P2860
P304
P356
10.1016/J.FOB.2015.09.007
P50
P577
2015-09-25T00:00:00Z